La Vie Health and Virotek Biosciences Partner to Advance the Next Generation of Precision Health
Ottawa, Ontario and Richmond Hill, Ontario--(Newsfile Corp. - September 15, 2026) - La Vie Health ("La Vie") and Virotek Biosciences...
Genetic Testing
Nabsys and Indiana University Collaborate to Advance Electronic Genome Mapping Applications in Hematologic Malignancies
Multi-year research collaboration will focus initially on AML and MDS while advancing Electronic Genome Mapping for broader hematologic research applicationsPROVIDENCE,...
Rhythm Pharmaceuticals Announces The New England Journal of Medicine Publication of Phase 3 TRANSCEND Trial Results in Acquired Hypothalamic Obesity
BOSTON, July 08, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming...
Fertility Sensor Market to Reach USD 2.80 Billion by 2033, Driven by At-Home Reproductive Monitoring Surge and Connected Health Integration – Verified Market Research®
The Global Fertility Sensor Market fueled by rising consumer demand for sensor-enabled ovulation tracking and conception planning tools. Wearable fertility...
Fertility Sensor Market to Reach USD 2.80 Billion by 2033, Driven by At-Home Reproductive Monitoring Surge and Connected Health Integration – Verified Market Research®
The Global Fertility Sensor Market fueled by rising consumer demand for sensor-enabled ovulation tracking and conception planning tools. Wearable fertility...
Days After Launch, Attunio Health Expands Precision Psychiatry Infrastructure with Quest Diagnostics and Getlabs
Quest Diagnostics and Getlabs strengthen Attunio's AI-powered, biomarker-driven infrastructure with blood and genetic testing from homeATLANTA, June 25, 2026 /PRNewswire/...
Children’s Hospital of Philadelphia Researchers Develop AI-Driven Tool to Aid in Selecting Genetic Tests for Diagnosis of Rare Diseases
RareDAI follows a clinician's chain-of-thought, allowing for reproducibility based on a series of standardized questionsPHILADELPHIA, June 24, 2026 /PRNewswire/ --...
Start Genetic Announces Second Annual Genetic Testing Action Day on July 25, 2026
Global awareness campaign highlights the importance of genetic diagnosis in an era of rapidly advancing genetic medicineLOS ANGELES, June 24,...
Phenomix Sciences Launches MyPhenome® Test Directly to Patients to Help Guide Weight Loss Treatment Based on Biology
Now available directly to patients, MyPhenome is the first and only precision obesity test that goes beyond GLP-1 treatment response...
Phenomix Sciences Launches MyPhenome® Test Directly to Patients to Help Guide Weight Loss Treatment Based on Biology
Now available directly to patients, MyPhenome is the first and only precision obesity test that goes beyond GLP-1 treatment response...
Cizzle Bio Announces Laboratory Validation of CIZ1B Biomarker Blood Test for Early Lung Cancer at OmniHealth Diagnostics
DALLAS, June 16, 2026 /PRNewswire/ -- Cizzle Bio, Inc., a Texas-based biotechnology company advancing biomarker blood tests for early detection of...
Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026
-- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI z-score reductions, reductions in fat...
Sharecare wins 14 Digital Health Awards in Spring 2026 competition
Company earns five Golds for its interactive patient education tools, health literacy content, and evidence-based behavioral health appsATLANTA, June 11,...
Rhythm Pharmaceuticals Announces Seven Abstracts Accepted for Presentation at ENDO 2026
BOSTON, May 29, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming...
Southern California Reproductive Center Joins Nucleus IVF+ Network as Patient Demand Accelerates
The move brings Genetic Optimization to one of the most sought-after fertility clinics in the U.S., following Nucleus’ rapid global...
Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology
– Real world data showed clinically meaningful BMI reductions with setmelanotide in 62 adults with 12-month data living with acquired...
Ambry Genetics’ CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution”
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics, a leader in clinical genomic testing, and a wholly owned subsidiary of Tempus AI, Inc....
Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- The latest GeneSight® Mental Health Monitor, a nationwide survey from Myriad...
GB HealthWatch Launches AI-Ready Genetic Reports for the GB Longevity100 Suite
AI-powered innovation transforms complex genetic data into clear, actionable insights for clinicians and individuals Genomics + AI for Longevity Transforming...
Laurent C.A. Melchior Tellier Returns to Original Role as CEO of Genomic Prediction
NEWARK, N.J., April 17, 2026 /PRNewswire/ -- Genomic Prediction, Inc., a leader in advanced genetic testing and reproductive genomics, announced...